Blackstone’s Artiva Biotherapeutics ARTV Stock Holding History
Bought
Maintained
Sold
Other funds holding ARTV
Blackstone's ARTV Position: Q2 2026 in Review
Blackstone opened a new position in Artiva Biotherapeutics (ARTV) in Q2 2026: 2,403,437 shares worth $23.3M. The stake represents 0.06% of the portfolio and ranks #72 among its holdings.
72 funds tracked by Wall St. Rank hold ARTV as of Q2 2026.
- Blackstone held 2,403,437 shares of Artiva Biotherapeutics worth $23.3M as of Q2 2026.
- Artiva Biotherapeutics was a new Blackstone position in Q2 2026.
- Artiva Biotherapeutics made up 0.06% of Blackstone's portfolio in Q2 2026, its #72 holding.
- 72 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.